Applied Dna Sciences Inc EBITDA margin
Qual é o EBITDA margin de Applied Dna Sciences Inc?
O EBITDA margin de Applied Dna Sciences Inc é -452.18%
Qual é a definição de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin de empresas na Setor Industrials em NASDAQ em comparação com Applied Dna Sciences Inc
O que Applied Dna Sciences Inc faz?
we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Empresas com ebitda margin semelhantes a Applied Dna Sciences Inc
- Eiger BioPharmaceuticals Inc tem EBITDA margin de -453.38%
- Desert Mountain tem EBITDA margin de -452.99%
- Macrogenics Inc tem EBITDA margin de -452.96%
- RevoluGROUP Canada tem EBITDA margin de -452.79%
- Atlantic Sapphire ASA tem EBITDA margin de -452.71%
- Heartsoft tem EBITDA margin de -452.66%
- Applied Dna Sciences Inc tem EBITDA margin de -452.18%
- NeuroScientific Biopharmaceuticals tem EBITDA margin de -451.90%
- Hammer Metals tem EBITDA margin de -450.60%
- Musgrave Minerals tem EBITDA margin de -448.62%
- Eargo tem EBITDA margin de -447.64%
- Selecta Biosciences Inc tem EBITDA margin de -446.27%
- Queste Communications Ltd tem EBITDA margin de -445.98%